Abstract
It is unclear how polyglutamine expansion is associated with the pathogenesis of Huntington disease (HD). Here, we provide evidence that polyglutamine expansion leads to the formation of large intracellular aggregates in vitro and in vivo. In vitro these huntingtin-containing aggregates disrupt normal cellular architecture and increase in frequency with polyglutamine length. Huntingtin truncated at nucleotide 1955, close to the caspase-3 cleavage site, forms perinuclear aggregates more readily than full-length huntingtin and increases the susceptibility of cells to death following apoptotic stimuli. Further truncation of huntingtin to nucleotide 436 results in both intranuclear and perinuclear aggregates. For a given protein size, increasing polyglutamine length is associated with increased cellular toxic-ity. Asymptomatic transgenic mice expressing full-length huntingtin with 138 polyglutamines form exclusively perinuclear aggregates in neurons. These data support the hypothesis that proteolytic cleavage of mutant huntingtin leads to the development of aggregates which compromise cell viability, and that their localization is influenced by protein length.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Huntington's Disease Collaborative Research Group.A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72, 971–983 (1993).
Goldberg, Y.P. et al. Absence of disease phenotype and intergenerational stability of the CAG repeat in transgenic mice expressing the human Huntington disease transcript. Hum. Mol. Genet. 5 177–185 (1996).
Mangiarini, L., et al. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87, 493–506 (1996).
Goldberg, Y.P. et al. Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract. Nature Genet. 13, 442–449 (1996).
Ikeda, H. et al. Expanded polyglutamine in the Machado-Joseph disease protein induces cell death in vitro and in vivo. Nature Genet. 13, 196–202 (1996).
Fraefel, C. et al. Helper virus-free transfer of Herpes Simplex Virus Type 1 plasmid vectors into neural cells. J. Virol. 70, 7190–7197 (1996).
Cunningham, C. & Davison, A.J. A cosmid-based system for constructing mutants of herpes simplex virus type 1.Virology 197, 116–124 (1993).
Tellez-Nagel, I., Johnson, A.B. & Terry, R.D. Ultrastructural and histochemical study of cerebral biopsies in Huntington's chorea. Adv. Neurol. 1, 387–397 (1973).
Tellez-Nagel, I., Johnson, A.B. & Terry, R.D. Studies on brain biopsies of patients with Huntington's chorea. J. Neuropath. Exper. Neurol. 33, 308–332 (1974).
Davies, S.W. et al. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 90, 537–548(1997).
DiFiglia, M. et al. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277, 199–1993 (1997).
Sapp, E. et al. Huntingtin localization in brains of normal and Huntington's disease patients. Ann. Neurol. 23, 2247–2255 (1997).
Palombella, V.J., Rando, O.J., Goldberg, A.L. & Maniatis, T. The ubiquitin-proteosome pathway is required for processing the NF-(B1 precursor protein and the activation of NF-Kp. Cell 78, 773–785 (1994).
Johnson, P.R. & Hochstrasser, M. SUMO-1: ubiquitin gains weight. Trends Cell Biol. 7, 408–413 (1997).
Kalchman, M.A. et al. Huntingtin is ubiquitinated and interacts with a specific ubiquitin conjugated enzyme. J. Biol. Chem. 271, 19385–19394 (1996).
Scherzinger, E. et al. Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo. Cell 90, 549–558 (1997).
Perutz, M.F., Johnson, T., Suzuki, M. & Finch, J.T. Glutamine repeats as polar zippers: their possible role in inherited neurodegenerative diseases. Proc. Natal. Acad. Sci. USA 91, 5355–5358 (1994).
Perutz, M.F. Glutamine repeats and inherited neurodegenerative diseases: molecular aspects. Curr. Opin. Struct Biol. 6, 848–858 (1996).
Paulson, H.L. et al. Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3. Neuron 19, 333–334 (1997).
Igarashi, S. et al. Suppression of aggregate formation and apoptosis by transglutaminase inhibitors in cells expressing truncated DRPLA protein with an expanded polyglutamine stretch. Nature Genet. 18, 111–117 (1998).
Wellington, C.L. & Hayden, M.R. Of molecular interactions, mice and mechanisms: new insights into Huntington's disease. Curr. Opin. Neurol. 10, 291–298 (1997).
Jordan, M., Schallhorn, A. & Wurm, F.M. Transfecting mammalian cells: optimization of critical parameters affecting calcium-phosphate precipitate formation. Nuceic Acids Res. 24, 596–601 (1996).
Kalchman, M.A. et al. HIP1, a human homolog of S. cerevisiae Sla2p, interacts with membrane-associated huntingtin in the brain. Nature Genet. 16, 44–53 (1997).
Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65, 55–63 (1983).
Carmichael, J. et al. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res. 47, 936–942 (1987).
Vistica, D.T. et al. Tetrazolium-based assays for cellular viability: a critical examination of selected parameters affecting formazan production. Cancer Res. 51, 2515–2520 (1991).
Couldwell, W.T. et al. Protein kinase C inhibitors induce apoptosis in human malignant glioma cell lines. FEBS Lett. 345, 43–46 (1994).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Martindale, D., Hackam, A., Wieczorek, A. et al. Length of huntingtin and its polyglutamine tract influences localization and frequency of intracellular aggregates. Nat Genet 18, 150–154 (1998). https://doi.org/10.1038/ng0298-150
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ng0298-150
This article is cited by
-
Label-free identification of protein aggregates using deep learning
Nature Communications (2023)
-
Amyloid modifier SERF1a interacts with polyQ-expanded huntingtin-exon 1 via helical interactions and exacerbates polyQ-induced toxicity
Communications Biology (2023)
-
A selective inhibitor of the NLRP3 inflammasome as a potential therapeutic approach for neuroprotection in a transgenic mouse model of Huntington’s disease
Journal of Neuroinflammation (2022)
-
Nuclear and cytoplasmic huntingtin inclusions exhibit distinct biochemical composition, interactome and ultrastructural properties
Nature Communications (2021)
-
HSP90 recognizes the N-terminus of huntingtin involved in regulation of huntingtin aggregation by USP19
Scientific Reports (2017)
